Gena Gore
Family · Indianapolis, INNPI 1376959692
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,229 of the $7,004 with a category attached, or 88.9%. It is spread thinly across 24 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,041 and has fallen 69.5% since, to $622 in 2025. Among family clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 358 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$804
- Sun Pharmaceutical Industries Inc.$710
- Novartis$690
- Regeneron Healthcare Solutions, Inc.$400
- Sanofi$381
- plus $3K from 18 others
What the payments were for
- Consulting fees$6199%
- Food & beverage$6,22989%
- Education$1562%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $1,317 |
| Lilly USA, LLC | 40 | $804 |
| Sun Pharmaceutical Industries Inc. | 43 | $710 |
| Novartis | 68 | $690 |
| Regeneron Healthcare Solutions, Inc. | 17 | $400 |
| Sanofi | 15 | $381 |
| Incyte Corporation | 17 | $338 |
| Galderma Laboratories, L.p. | 16 | $337 |
| Johnson & Johnson | 15 | $331 |
| E.r. Squibb & Sons, L.L.C. | 12 | $272 |
| Pfizer | 11 | $257 |
| UCB, Inc. | 11 | $247 |
| LEO Pharma Inc. | 8 | $165 |
| VYNE Pharmaceuticals Inc. | 1 | $125 |
| Amgen | 5 | $109 |
| Dermavant Sciences, Inc. | 6 | $101 |
| Mayne Pharma Commercial LLC | 4 | $91 |
| Boehringer Ingelheim | 4 | $86 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $78 |
| Arcutis Biotherapeutics, Inc. | 3 | $53 |
| Merz North America, Inc. | 2 | $43 |
| Journey Medical Corporation | 2 | $34 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Biofrontera Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,004 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 13 | $83,072 |
| Dupixent PenDupilumab | 13 | $48,279 |
| Fluorouracil | 22 | $1,620 |
| Fluocinonide | 19 | $670 |
| Ketoconazole | 35 | $506 |
| Triamcinolone Acetonide | 41 | $336 |
| Clindamycin Phosphate | 13 | $259 |
| Hydrocortisone | 17 | $112 |
Paid to pharmacies, not to this prescriber.
Other family in Indianapolis
- Tina SizemoreIndianapolis$888K
- Marla MosesIndianapolis$142K
- Leslye FisherIndianapolis$73K
- Alicia WettrickIndianapolis$72K
- Christine BaltIndianapolis$30K
- Kathryn KennedyIndianapolis$29K
- Andrea RandallIndianapolis$27K
- Deidre ArmsIndianapolis$26K
- Carrie GravesIndianapolis$16K
- Dominique LevequeIndianapolis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.